Codex Biosciences International Private Limited - Company Profile

It is a agriculture private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2000.
2000 Visakhapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Codex Biosciences International Private Limited

Codex Biosciences International Private Limited, a active private limited company, was established on 09 February 2000 in Visakhapatnam, Andhra Pradesh, India. Engaging in fisheries & aquaculture within the manufacturing sector, it holds CIN: U51397AP2000PTC033511. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.61 M.

Formerly known as Coion Technologies Private Limited. It upholds a compliant status. Employing 20 professional, Its leadership includes Rajakumari Challagulla (Director), Vidya Sagar Challagulla (Managing Director). Past directors included Vidya Sagar Challagulla. It holds ₹3.70 Cr open charges and ₹3.02 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D.No. 49-38-14/7, Beside Icwai Building, Nggo'S Colony, Akkayapalem,, Visakhapatnam, Andhra Pradesh, 530016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397AP2000PTC033511

  • Registration Number

    033511

  • Incorporation Date

    09 February 2000

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹2.61 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 2.61 M
  • Company Age 26 Year, 21 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.70 Cr
  • Satisfied Charges ₹ 3.02 Cr
  • Revenue Growth **** 8.99%
  • Profit Growth **** 18.46%
  • Ebitda **** 2.59%
  • Net Worth 14.82%
  • Total Assets **** 3.56%
Company report

Codex Biosciences International Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Codex Biosciences International Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Codex Biosciences International Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajakumari Challagulla Director 30 Nov 2001 Current
Vidya Sagar Challagulla Managing Director 09 Feb 2000 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Nov 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Codex Biosciences International.

Codex Biosciences International Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.99% increase. The company also saw a substantial improvement in profitability, with a 18.46% increase in profit. The company's net worth Soared by an impressive increase of 14.82%.

Codex Biosciences International revenue growth over time
Codex Biosciences International profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 8.99%
*******
*******
*******
*******
Revenue from Operations
*******
 9.09%
*******
*******
*******
*******
Total Assets
*******
 3.56%
*******
*******
*******
*******
Profit or Loss
*******
 18.46%
*******
*******
*******
*******
Net Worth
*******
 14.82%
*******
*******
*******
*******
EBITDA
*******
 2.59%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Codex Biosciences International?

Unlock access to Codex Biosciences International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹37,000,000.00

Satisfied Charges

₹30,200,000.00

Charges Breakdown by Lending Institutions
  • Others : 3.70 Cr
Latest Charge Details
Date Lender Amount Status
11 Jan 2023 Others ₹4.50 M Open
08 Apr 2022 Others ₹2.90 M Open
16 Sep 2020 Others ₹3.30 M Open
08 Mar 2019 Others ₹2.63 Cr Open
22 Nov 2011 Others ₹2.90 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Codex Biosciences International?

Codex Biosciences International has a workforce of 20 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Codex Biosciences International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Codex Biosciences International's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Codex Biosciences International
Recent Activity within the Organization
  • Annual General Meeting

    Codex Biosciences International Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Codex Biosciences International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 4.50 M with Charge ID 100665861 was registered on 11 Jan 2023. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 2.90 M with Charge ID 100556284 was registered on 08 Apr 2022. was documented.

  • Charges

    A charge with Others amounted to Rs. 3.30 M with Charge ID 100368823 was registered on 16 Sep 2020. was recorded as a recent event.

  • Charges

    A charge registered on 22 Nov 2011 via Charge ID 10320669 with Others was fully satisfied on 15 Mar 2019. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Codex Biosciences International Private Limited?

The CIN of Codex Biosciences International Private Limited is U51397AP2000PTC033511.

Where is Codex Biosciences International Private Limited headquartered?

Codex Biosciences International Private Limited is headquartered at D.No. 49-38-14/7, Beside Icwai Building, Nggo'S Colony, Akkayapalem,, Visakhapatnam, Andhra Pradesh, 530016.

When was Codex Biosciences International Private Limited incorporated?

Codex Biosciences International Private Limited was incorporated on 09 February 2000.

Who are the current directors of Codex Biosciences International Private Limited?

The current directors of Codex Biosciences International Private Limited are

What is the primary industry of Codex Biosciences International Private Limited?

The primary industry of Codex Biosciences International Private Limited is Manufacturing.

Is Codex Biosciences International Private Limited a listed company?

Codex Biosciences International Private Limited is unlisted.

What is the capital structure of Codex Biosciences International Private Limited?

The authorized capital of Codex Biosciences International Private Limited is ₹5.00 M, and the paid-up capital is ₹2.61 M.

What is the compliance status of Codex Biosciences International Private Limited?

The compliance status of Codex Biosciences International Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available